Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
Active, not recruiting · NCT04591392 · Registry updated 2025-05-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, atrial septal defect, cardiovascular disorder, congenital heart disease, heart disorder, heart septal defect | Active, not recruiting | Not applicable | 2025-05-07 | NCT04591392 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| atHeart Medical | 1 |
32 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.